Smartphone 12-lead ECG—Exciting but must be handled with care - 16/08/20
Doi : 10.1016/j.ahj.2020.03.004
Joseph Brent Muhlestein, MD a, b, ⁎ 
, Joseph Boone Muhlestein, MD a, b, Jeffrey L. Anderson, MD a, b, Charles F. Bethea, MD c, Harry W. Severance, MD d, Robert J. Mentz, MD e, Gregory W. Barsness, MD f, Alejandro Barbagelata, MD g, David Albert, MD h, Viet T. Le, PA-C a, i, T. Jared Bunch, MD b, j, Frank Yanowitz, MD a, b, Heidi T. May, PhD a, Benjamin Chisum, BS a, Brianna S. Ronnow, MS a
, Joseph Boone Muhlestein, MD a, b, Jeffrey L. Anderson, MD a, b, Charles F. Bethea, MD c, Harry W. Severance, MD d, Robert J. Mentz, MD e, Gregory W. Barsness, MD f, Alejandro Barbagelata, MD g, David Albert, MD h, Viet T. Le, PA-C a, i, T. Jared Bunch, MD b, j, Frank Yanowitz, MD a, b, Heidi T. May, PhD a, Benjamin Chisum, BS a, Brianna S. Ronnow, MS afor the Duke University Cooperative Cardiovascular Society (DUCCS) investigators
a Intermountain Medical Center, Intermountain Heart Institute, Salt Lake City, UT
b The University of Utah, Department of Internal Medicine, Salt Lake City, UT
c Integris Heart Hospital, Oklahoma City, OK
d Erlanger Institute for Clinical Research, UT College of Medicine, Chattanooga, TN
e Duke University, Durham, NC
f Mayo Clinic, Rochester, MN
g Catholic University, Buenos Aires, Argentina
h AliveCor Corporation, San Francisco, CA
i Rocky Mountain University of Health Professions, Masters of Physician Assistant Studies Program, Provo, UT
j Stanford University, Department of Internal Medicine, Palo Alto, CA
⁎Reprint requests: Joseph Brent Muhlestein, MD, Intermountain Heart Institute, 5121 S Cottonwood St, Salt Lake City, UT 84107.Intermountain Heart Institute5121 S Cottonwood St,Salt Lake CityUT84107
Le texte complet de cet article est disponible en PDF.
© 2020
Elsevier Inc. Tous droits réservés.
Vol 226
P. 269 - août 2020 Retour au numéro
Article précédent
- Smartphone 12-lead ECG—Exciting but must be handled with care
- Thomas Lindow, Olle Pahlm
- Corrigendum to “Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry subanalysis” Am Heart J (2020)
- Masaharu Akao, Takeshi Yamashita, Shinya Suzuki, Ken Okumura, J-ELDAF investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?